Gsk (GSK) Property, Plant & Equipment (Net) Growth (1y) (2016 - 2025)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
PP&E (Net) Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
43.66% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
11.49% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
8.59% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
3,250.86% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
22.98% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
4.00% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
5.75% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
6.17% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
4.70% |
| Date | Value |
|---|
| Dec 31, 2025 |
4.70% |
| Dec 31, 2024 |
5.79% |
| Dec 31, 2023 |
6.85% |
| Dec 31, 2022 |
-21.74% |
| Dec 31, 2021 |
-0.36% |
| Dec 31, 2020 |
0.99% |
| Dec 31, 2019 |
-6.50% |
| Dec 31, 2018 |
-1.31% |
| Dec 31, 2017 |
7.31% |
| Dec 31, 2016 |
-8.41% |
